Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis

J Cyst Fibros. 2016 Mar;15(2):242-50. doi: 10.1016/j.jcf.2015.08.003. Epub 2015 Aug 30.

Abstract

Background: Several microbial studies reported gut microbiota dysbiosis in patients with cystic fibrosis (CF). The functional consequences of this phenomenon are poorly understood. Faecal metaproteomics allows the quantitative analysis of host and microbial proteins to address functional changes resulting from this dysbiosis.

Methods: We analysed faecal protein extracts from fifteen patients with CF that have pancreatic insufficiency and from their unaffected siblings by shotgun proteomics. Novel computational and statistical tools were introduced to evaluate changes in taxonomic composition and protein abundance.

Results: Faecal protein extracts from patients with CF were dominated by host proteins involved in inflammation and mucus formation. Taxonomic analysis of the microbial proteins confirmed the strong reduction of butyrate reducers such as Faecalibacterium prausnitzii and increase of Enterobacteriaceae, Ruminococcus gnavus and Clostridia species.

Conclusion: Faecal metaproteomics provides insights in intestinal dysbiosis, inflammation in patients with CF and can be used to monitor different disease markers in parallel.

Keywords: Cystic fibrosis; Dysbiosis; Metaproteomics; Unipept.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Clostridium / isolation & purification
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / microbiology
  • Dysbiosis / diagnosis*
  • Dysbiosis / etiology
  • Dysbiosis / microbiology
  • Enterobacteriaceae / isolation & purification
  • Feces / microbiology*
  • Female
  • Humans
  • Inflammation / diagnosis*
  • Inflammation / etiology
  • Inflammation / microbiology
  • Male
  • Proteomics / methods*